Lifecore Biomedical, Inc. \de\ SEC filings LFCR

Lifecore Biomedical, Inc. \de\ has 1,005 filings in SEC EDGAR's recent list, going back to May 16, 2012. Its latest annual report, Form 10-KT, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (other events). The company's fiscal year ends on May 25.

Lifecore Biomedical, Inc. \de\ SEC filings
Form Description Filed Period
10-KT Transition report Mar 16, 2026 Dec 31, 2025
10-K Annual report Aug 7, 2025 May 25, 2025
10-K Annual report Aug 26, 2024 May 26, 2024
10-K Annual report Mar 20, 2024 May 28, 2023
10-K/A Amended annual report Mar 16, 2023 May 29, 2022
10-K Annual report Sep 14, 2022 May 29, 2022
10-K Annual report Jul 29, 2021 May 30, 2021
10-K Annual report Aug 14, 2020 May 31, 2020
10-K Annual report Aug 1, 2019 May 26, 2019
10-K Annual report Aug 9, 2018 May 27, 2018
10-K/A Amended annual report Mar 15, 2018 May 28, 2017
10-K/A Amended annual report Aug 15, 2017 May 28, 2017
10-K Annual report Aug 11, 2017 May 28, 2017
10-K Annual report Aug 1, 2016 May 29, 2016
10-K Annual report Jul 31, 2015 May 31, 2015
10-K Annual report Aug 1, 2014 May 25, 2014
10-K Annual report Aug 7, 2013 May 26, 2013
10-K Annual report Aug 8, 2012 May 27, 2012

Showing 18 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
LFCR (Nasdaq)
Fiscal year ends
May 25
Incorporated in
DE
Headquarters
Chaska, MN
SEC filer status
Accelerated filer, Smaller reporting company
SEC CIK
1005286
Former names
LANDEC CORP \CA\ (until Nov 7, 2022)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.